Gentechnologische Medikamente und Gentherapie. [Gene technology drugs and gene therapy]

Details

Serval ID
serval:BIB_B03B315C9320
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Gentechnologische Medikamente und Gentherapie. [Gene technology drugs and gene therapy]
Journal
Therapeutische Umschau
Author(s)
Blum  H. E., Moradpour  D.
ISSN
0040-5930 (Print)
Publication state
Published
Issued date
12/1999
Volume
56
Number
12
Pages
730-7
Notes
English Abstract
Journal Article
Review --- Old month value: Dec
Abstract
The principles of recombinant DNA technology are illustrated based on the biology of somatic cells with transcription of chromosomal DNA into messenger RNA and its translation into protein. Recombinant DNA technology allows the cloning, identification and characterization of genes and their expression with the production of medically relevant proteins. The products of recombinant DNA technology are cloned genes on the one hand. These may be useful for molecular diagnosis and gene therapy. On the other hand they comprise recombinant proteins which may be useful in the diagnosis, therapy and prevention of human diseases.
Keywords
Animals Cloning, Molecular Forecasting Gene Therapy/*trends Humans Recombinant Proteins/*therapeutic use
Pubmed
Create date
25/01/2008 17:05
Last modification date
20/08/2019 16:19
Usage data